Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Teekay
TK
$1.01B
| $2.59M | ﹤0.01% |
374,291
-231,350
| -38% | -$1.78M |
|
2602
argenx
ARGX
$53.4B
| $2.59M | ﹤0.01% |
4,214
+755
| +22% | +$442K |
|
2603
Monte Rosa Therapeutics
GLUE
$1.4B
| $2.57M | ﹤0.01% |
370,472
+23,974
| +7% | +$180K |
|
2604
Cerus
CERS
$433M
| $2.57M | ﹤0.01% |
1,666,366
-88,174
| -5% | -$152K |
|
2605
Haleon
HLN
$43.5B
| $2.54M | ﹤0.01% |
265,744
+62,161
| +31% | +$608K |
|
2606
Allogene Therapeutics
ALLO
$649M
| $2.53M | ﹤0.01% |
1,188,838
+9,990
| +0.8% | +$24.6K |
|
|
SAGE
2607
DELISTED
Sage Therapeutics
SAGE
| $2.51M | ﹤0.01% |
462,309
+10,116
| +2% | +$61.8K |
|
2608
Honda
HMC
$39.1B
| $2.51M | ﹤0.01% |
87,924
-10,862
| -11% | -$307K |
|
2609
GoodRx Holdings
GDRX
$1.04B
| $2.5M | ﹤0.01% |
538,588
+58,465
| +12% | +$321K |
|
2610
Cooper-Standard Automotive
CPS
$523M
| $2.5M | ﹤0.01% |
184,664
-133,528
| -42% | -$1.91M |
|
|
CBLL
2611
CeriBell Inc
CBLL
$671M
| $2.5M | ﹤0.01% |
+96,582
| New | +$2.63M |
|
2612
Fulcrum Therapeutics
FULC
$273M
| $2.47M | ﹤0.01% |
526,045
-43,140
| -8% | -$159K |
|
2613
Hamilton Insurance Group
HG
$3.57B
| $2.44M | ﹤0.01% |
128,136
+17,342
| +16% | +$321K |
|
2614
Groupon
GRPN
$1.05B
| $2.44M | ﹤0.01% |
200,436
+1,449
| +0.7% | +$15.2K |
|
2615
Lennar Class B
LEN.B
$19.4B
| $2.42M | ﹤0.01% |
+19,304
| New | +$2.9M |
|
2616
Ranpak Holdings
PACK
$439M
| $2.42M | ﹤0.01% |
352,346
+7,796
| +2% | +$53.4K |
|
|
RVNC
2617
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.42M | ﹤0.01% |
797,299
+6,462
| +0.8% | +$28.1K |
|
2618
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $2.41M | ﹤0.01% |
122,019
+32,393
| +36% | +$739K |
|
2619
The Honest Company
HNST
$402M
| $2.41M | ﹤0.01% |
348,133
+122,566
| +54% | +$694K |
|
2620
Microvision
MVIS
$6.21M
| $2.4M | ﹤0.01% |
1,832,066
+134,479
| +8% | +$141K |
|
2621
SmartRent
SMRT
$195M
| $2.39M | ﹤0.01% |
1,367,677
-147,447
| -10% | -$247K |
|
2622
Tyra Biosciences
TYRA
$1.9B
| $2.37M | ﹤0.01% |
170,600
-3,137
| -2% | -$56.9K |
|
2623
Latham Group
SWIM
$629M
| $2.37M | ﹤0.01% |
340,603
+7,397
| +2% | +$49.5K |
|
2624
Woodside Energy
WDS
$44.6B
| $2.35M | ﹤0.01% |
150,770
+10,110
| +7% | +$162K |
|
2625
MBIA
MBI
$261M
| $2.35M | ﹤0.01% |
363,576
-20,906
| -5% | -$108K |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.